What Context Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lehr Martin A. | Chief Executive Officer | Jun 09 | Open-market buy · P | +100,000 | $0.70 | +$70.1K | 920,190 |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | Jun 06 | Open-market buy · P | +20,000 | $0.58 | +$11.5K | 29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | Jun 06 | Open-market buy · P | +40,010 | $0.64 | +$25.5K | 80,010 |
| Lehr Martin A. | Chief Executive Officer | Feb 21 | Open-market buy · P | +5,823 | $0.84 | +$4.9K | 159,701 |
| Lehr Martin A. | Chief Executive Officer | Feb 13 | Open-market buy · P | +5,606 | $0.87 | +$4.9K | 153,878 |
| Lehr Martin A. | Chief Executive Officer | Feb 06 | Open-market buy · P | +5,040 | $0.97 | +$4.9K | 148,272 |
| Lehr Martin A. | Chief Executive Officer | Jan 30 | Open-market buy · P | +7,027 | $0.70 | +$4.9K | 143,232 |
| Lehr Martin A. | Chief Executive Officer | Jan 23 | Open-market buy · P | +6,839 | $0.72 | +$4.9K | 136,205 |
| Lehr Martin A. | Chief Executive Officer | Jan 17 | Open-market buy · P | +6,783 | $0.74 | +$5K | 129,366 |
| Lehr Martin A. | Chief Executive Officer | Dec 16 | Open-market buy · P | +20,000 | $0.74 | +$14.8K | 122,583 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | Dec 16 | Open-market buy · P | +25,000 | $0.74 | +$18.5K | 40,000 |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | Dec 09 | Open-market buy · P | +6,000 | $0.85 | +$5.09K | 9,000 |
| Lehr Martin A. | Chief Executive Officer | Aug 19 | Open-market buy · P | +13,000 | $1.85 | +$24.1K | 102,583 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | Aug 17 | Open-market buy · P | +15,000 | $1.80 | +$27K | 15,000 |
| Sahmoud Tarek | Chief Medical Officer | Aug 16 | Open-market buy · P | +10,000 | $1.95 | +$19.5K | 10,000 |
| Lehr Martin A. | Chief Executive Officer | Dec 16 | Open-market buy · P | +13,000 | $3.22 | +$41.8K | 820,190 |
| Lehr Martin A. | Chief Executive Officer | Oct 22 | Derivative Conversion · C | +586,476 | — | — | 849,878 |
| Lehr Martin A. | Chief Executive Officer | Oct 22 | Derivative Conversion · C | +210,722 | — | — | 263,402 |
| Lehr Martin A. | Chief Executive Officer | Oct 22 | Out-of-money Exercise · O | +52,680 | $7.14 | +$376K | 52,680 |
| Lehr Martin A. | Chief Executive Officer | Oct 22 | Open-market buy · P | +10,000 | $5.00 | +$50K | 99,583 |
Loading...
